StonvexLoading…
StonvexStonvexStonvexCore line items from BLDR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.29B | $15.19B | $11.83B | $7.89B |
Operating Income | $16.52M | $786.28M | $724.50M | $495.73M |
Net Income | $-47.41M | $435.20M | $403.72M | $185.03M |
EPS (Diluted) | $-0.43 | $3.89 | $3.60 | $2.50 |
Total Assets | $11.30B | $11.24B | $11.43B | $11.46B |
Total Liabilities | $7.30B | $6.89B | $7.11B | $7.29B |
Cash & Equivalents | $98.34M | $181.75M | $296.16M | $87.02M |
Free Cash Flow OCF − CapEx | $40.71M | $853.28M | $746.56M | $284.65M |
Shares Outstanding | 107.52M | 110.58M | 110.55M | 110.54M |